Multivariate Analyses of Mometasone Furoate versus Fixed Dose Combination of Salmeterol and Fluticasone Propionate in Mild Persistent Asthma Using an Administrative Claims Database
A series of multivariate retrospective administrative claims database analyses to compare the impact on treatment charges and patient health outcomes between mometasone furoate inhaler (MF, Asmanex®) and the fixed-dose combination inhaler of fluticasone propionate and salmeterol (FPS, Advair®) in th...
Saved in:
Published in: | Journal of allergy and clinical immunology Vol. 123; no. 2; p. S44 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
St. Louis
Mosby, Inc
01-02-2009
Elsevier Limited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A series of multivariate retrospective administrative claims database analyses to compare the impact on treatment charges and patient health outcomes between mometasone furoate inhaler (MF, Asmanex®) and the fixed-dose combination inhaler of fluticasone propionate and salmeterol (FPS, Advair®) in the mild, persistent asthma patient population was conducted. |
---|---|
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/j.jaci.2008.12.137 |